- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
A monoclonal antibody (mAb) is an antibody made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a single parent cell. These antibodies can have a monovalent affinity, binding only to the same epitope. The objective is that this treatment will stimulate the patient’s immune system and have been used to treat diseases such as cancer, autoimmune diseases and Alzheimer.
Showing 37–48 of 225 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD20 |
Monoclonal Antibody , Biosimilar |
Rixathon® |
10 mg/mL |
– |
2 mg |
-80 °C |
03/2026 |
311,00 € |
||
sclerostin |
Monoclonal Antibody |
Evenity® |
90 mg/mL |
– |
4 mg |
tba |
tba |
219,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
Kevzara® |
175 mg/mL |
– |
7 mg |
tba |
tba |
297,00 € |
||
IL-6 |
Monoclonal Antibody |
Enspryng® |
150 mg/mL |
– |
4 mg |
tba |
tba |
1.540,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
yes |
6 mg |
-80°C |
11/2022 |
324,90 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
12/2017 |
301,50 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
02/2019 |
301,50 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6mg |
-80°C |
12/2022 |
301,50 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
03/2018 |
301,50 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
09/2019 |
301,50 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
06/2018 |
301,50 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
12/2018 |
301,50 € |
||
IL-6 |
Monoclonal Antibody |
Sylvant® |
20 mg/mL |
– |
2 mg |
-80°C |
02/2023 |
199,80 € |
||
IL-36R |
Monoclonal Antibody |
Spevigo |
60 mg/mL |
– |
9 mg |
tba |
tba |
2.888,00 € |
||
CP (classical pathway) |
Monoclonal Antibody |
Enjaymo® |
50 mg/mL |
– |
20 mg |
tba |
tba |
301,00 € |
||
TSLP |
Monoclonal Antibody |
Tezspire® |
110 mg/mL |
– |
5.5 mg |
tba |
tba |
404,00 € |
||
IL-23 |
Monoclonal Antibody |
Ilumetri® |
100 mg/mL |
– |
4 mg |
tba |
tba |
794,00 € |
||
SARS-CoV-2 Spike |
Monoclonal Antibody |
Evusheld® |
100 mg/mL |
– |
4 mg |
tba |
tba |
515,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
10/2021 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
05/2018 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
03/2019 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
05/2019 |
115,20 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
03/2020 |
115,20 € |
||
HER2 |
Monoclonal Antibody , Biosimilar |
Herzuma® |
21 mg/mL |
– |
6 mg |
tba |
tba |
356,00 € |
||
HER2 |
Monoclonal Antibody , Biosimilar |
Ontruzant® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Monoclonal Antibody , Biosimilar |
Kanjinti® |
21 mg/mL |
– |
6 mg |
-80°C |
01/2025 |
356,00 € |
||
HER2 |
Monoclonal Antibody , Biosimilar |
Zercepac® |
21 mg/mL |
– |
6 mg |
-80°C |
08/2026 |
356,00 € |
||
HER2 |
Monoclonal Antibody , Biosimilar |
Ogivri® |
21 mg/mL |
– |
6 mg |
-80°C |
10/2025 |
356,00 € |
||
HER2 |
Monoclonal Antibody , Biosimilar |
Trazimera® |
21 mg/mL |
– |
2 mg |
-80 °C |
09/2026 |
159,00 € |
||
HER2 |
Monoclonal Antibody |
Herceptin® |
21 mg/mL |
– |
2 mg |
-80°C |
08/2020 |
147,60 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin